PositionDirector of Malignant Hematology Program/Saint Luke’s Cancer InstituteResearch FocusDr. Shahzad Raza's research interests include incorporation of monoclonal immunotherapy in combination of IMiDs and proteasome inhibitor in the management... Read More
Thanks to our Myeloma Crowd Community sponsors:
. . .